Explore the latest books of this year!
Bookbot

Drugs and the Pharmaceutical Sciences - 175: Protein Formulation and Delivery

Second Edition

Parameters

  • 376 pages
  • 14 hours of reading

More about the book

This title is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed. Because many developments in the field have emerged since the publication of the First Edition, this Second Edition addresses important new patient-friendly developments in the field, such as formulation for implantable devices, needle-free formulation and delivery approaches, and oral delivery of proteins.

Book purchase

Drugs and the Pharmaceutical Sciences - 175: Protein Formulation and Delivery, Eugene J. McNally, Jayne E. Hastedt

Language
Released
2007
product-detail.submit-box.info.binding
(Hardcover),
Book condition
Very Good
Price
€45.99

Payment methods

No one has rated yet.Add rating

Title
Drugs and the Pharmaceutical Sciences - 175: Protein Formulation and Delivery
Subtitle
Second Edition
Language
English
Publisher
CRC Press
Released
2007
Format
Hardcover
Pages
376
ISBN10
0849379490
ISBN13
9780849379499
Series
Description
This title is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed. Because many developments in the field have emerged since the publication of the First Edition, this Second Edition addresses important new patient-friendly developments in the field, such as formulation for implantable devices, needle-free formulation and delivery approaches, and oral delivery of proteins.